Clinical Research Platform Into Molecular Testing, Treatment and Outcome of (Non-)Small Cell Lung Carcinoma Patients
This study, called CRISP, is open to adults in Germany who have been diagnosed with lung cancer, either non-small cell lung cancer (NSCLC) or small cell lung cancer (SCLC). It's not a trial where you receive a new drug; instead, it observes what's happening already. The study collects information on how patients are diagnosed, the tests they have, the treatments they receive, and how they feel and get on over time. This helps researchers understand the care that patients are currently getting and find ways to make it even better. They also look at things like quality of life and how patients and doctors talk to each other. Information is gathered, sometimes including tissue samples, to help with future research.
At a glance
What is this study about?
Imagine a big health snapshot of many lung cancer patients across Germany. That's essentially what the CRISP study aims to do. It's a research project designed to help doctors and researchers understand more about how lung cancer, both non-small cell (NSCLC) and small cell (SCLC) types, is being diagnosed and treated in everyday medical practice. They want to see what tests are being used, what treatments patients are receiving, and how these treatments affect their lives and health over time.
The main goal is to gather detailed information about real patients with lung cancer. This includes looking at special tests called molecular biomarker tests, which help tailor treatments. By collecting this information, the study can help identify what's working well in current care and where improvements might be made. It's like collecting puzzle pieces to see the full picture of lung cancer care, which can then be used to develop better guidelines and advice for doctors.
Another important part of CRISP is understanding how patients feel. The study will ask about quality of life and feelings like anxiety or sadness. This helps make sure that treatments not only fight the cancer but also help patients live as well as possible. They are also setting up a collection of tissue samples, which might be used for important new research in the future to learn even more about lung cancer.
Key takeaways
- This study collects real-world information on lung cancer care.
- It aims to improve future diagnosis and treatment for lung cancer.
- No new treatments or medicines are given as part of the study.
- You'll share information about your current care and complete questionnaires.
- Your contribution helps other lung cancer patients.
- You can stop participating at any time.
Who may be eligible?
To take part in this study, you need to be at least 18 years old. You also need to be able to understand the study information and be willing to sign a consent form, which shows you agree to participate. You'll also need to be able to fill out some questionnaires about how you're feeling.
This study is for people diagnosed with non-small cell lung cancer (NSCLC) or small cell lung cancer (SCLC). For NSCLC, this includes different stages, from early up to advanced cancer that has spread. For SCLC, it includes all stages.
If you're starting your first lung cancer treatment, or have just been diagnosed and are receiving supportive care, you might be eligible. Your doctor will be able to confirm if you meet all the specific requirements.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- Are you 18 years old or older?
- Do you have non-small cell lung cancer or small cell lung cancer?
- Are you willing to complete questionnaires about how you feel?
- Are you able to understand the study information and give your consent?
- Have you recently started your first lung cancer treatment, or recently diagnosed and receiving supportive care?
What does participation involve?
If you decide to take part in this study, you won't be given any new medicines or treatments as part of the research. Instead, the study will simply collect information about the tests and treatments you are already receiving as part of your normal care. This includes details about your diagnosis, the results of any special tests, and the treatments your doctor has prescribed for you.
You will also be asked to complete questionnaires at different times. These questionnaires will ask about your quality of life and how you are feeling, such as if you experience anxiety or sadness. Some questionnaires might also look at how you communicate with your care team. The study collects this information over time to see how things change. You'll continue to see your own doctors for your usual care, and the study will simply gather details from your medical records and your own answers to the questionnaires.
Potential risks and benefits
Locations (1)
- Pius-HospitalVerified postcodeOldenburg, Germany· Recruiting
Common questions
Will I get a new treatment if I join this study?
No, this study only collects information about your usual care; you won't receive any new treatments as part of it.
Do I need to travel for extra appointments?
No, you will have your usual appointments with your doctor. The study will mainly collect information from these visits and through questionnaires you complete.
What kind of information will they collect about me?
They will collect details about your diagnosis, tests you've had, treatments you've received, and how you feel through questionnaires.
Will my personal details be kept private?
Yes, all your information will be handled confidentially and kept private according to strict rules.
How long will I be in the study?
The study will collect information over a period of time, following your care as it happens. Your doctor can give you more specific details.
How to find out more
Annika Groth
Always speak to your GP or specialist before deciding to take part in a study.
Interested in taking part?
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.